These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 18520307)

  • 1. Discussion - clinical trials and combination therapies in lung cancer. Clinical trial design.
    J Thorac Oncol; 2008 Jun; 3(6 Suppl 2):S176-8. PubMed ID: 18520307
    [No Abstract]   [Full Text] [Related]  

  • 2. Discussion - other lung cancer targets.
    J Thorac Oncol; 2008 Jun; 3(6 Suppl 2):S175. PubMed ID: 18520306
    [No Abstract]   [Full Text] [Related]  

  • 3. Chemotherapy helps patients with advanced non-small cell carcinoma of the lung.
    Socinski MA; Detterbeck FC; Rivera MP; Egan TM; Halle J; Rosenman J
    N C Med J; 1996; 57(5):281-6. PubMed ID: 8854691
    [No Abstract]   [Full Text] [Related]  

  • 4. Adjuvant chemotherapy for non-small-cell lung cancer: a fading effect?
    Besse B; Le Chevalier T
    J Clin Oncol; 2008 Nov; 26(31):5014-7. PubMed ID: 18809602
    [No Abstract]   [Full Text] [Related]  

  • 5. Clinical trials referral resource. Clinical trials in non-small-cell lung cancer.
    Saxman SB; Blatner GL; Cheson BD
    Oncology (Williston Park); 1999 Oct; 13(10):1384, 1387-8. PubMed ID: 10549565
    [No Abstract]   [Full Text] [Related]  

  • 6. [Taxol in bronchial carcinoma].
    Gatzemeier U
    Med Klin (Munich); 1996 Dec; 91 Suppl 2():1-6. PubMed ID: 9082171
    [No Abstract]   [Full Text] [Related]  

  • 7. Can weight loss at presentation predict patient outcome in lung cancer?
    Temel J
    Nat Clin Pract Oncol; 2004 Dec; 1(2):68-9. PubMed ID: 16264819
    [No Abstract]   [Full Text] [Related]  

  • 8. [Therapeutic management of non-small-cell lung carcinoma (NSCLC) of stage III A].
    Mornex F
    Rev Pneumol Clin; 2001 Nov; 57(5 Pt 2):S29-32. PubMed ID: 11924239
    [No Abstract]   [Full Text] [Related]  

  • 9. Pemetrexed pathway-associated germline polymorphisms: a useful tool for treatment individualization?
    Buikhuisen WA; Burgers JA; Vincent AD; Schellens JH; Beijnen JH; Smit EF; Joerger M
    J Clin Oncol; 2010 Sep; 28(27):e482-3; author reply e484. PubMed ID: 20606096
    [No Abstract]   [Full Text] [Related]  

  • 10. [Therapeutic strategies in advanced non-small cell bronchial cancers: combinations without platin drugs].
    Postmus P
    Rev Pneumol Clin; 2002 Nov; 58(5 Pt 2):3S48-50. PubMed ID: 12538936
    [No Abstract]   [Full Text] [Related]  

  • 11. Elderly patients with advanced non-small-cell lung cancer.
    Belani CP
    Clin Lung Cancer; 2003 Sep; 5(2):76. PubMed ID: 14596687
    [No Abstract]   [Full Text] [Related]  

  • 12. Patient selection criteria and the FLEX Study.
    Herbst RS; Hirsch FR
    Lancet; 2009 May; 373(9674):1497-8. PubMed ID: 19410696
    [No Abstract]   [Full Text] [Related]  

  • 13. [New trends in adjuvant chemotherapy for non-small-cell lung cancer].
    Dediu M; Alexandru A; Median D; Vremeş G
    Pneumologia; 2005; 54(2):89-93. PubMed ID: 16536008
    [No Abstract]   [Full Text] [Related]  

  • 14. [Non-small cell bronchial carcinoma. A conceptual evolution].
    Depierre A
    Rev Pneumol Clin; 1991; 47(4):153-4. PubMed ID: 1663653
    [No Abstract]   [Full Text] [Related]  

  • 15. Pemetrexed plus bevacizumab for second-line therapy of non-small-cell lung cancer: the importance of patient selection.
    Araujo AM
    J Clin Oncol; 2010 Mar; 28(8):e131; author reply e132. PubMed ID: 20100954
    [No Abstract]   [Full Text] [Related]  

  • 16. Re-evaluating duration of therapy in advanced non-small-cell lung cancer: is it really duration or is it more about timing and exposure?
    Socinski MA
    J Clin Oncol; 2009 Jul; 27(20):3268-70. PubMed ID: 19470913
    [No Abstract]   [Full Text] [Related]  

  • 17. [Adjuvant chemotherapy in the early stages of non-small cell bronchial cancers].
    Le Chevalier T
    Rev Pneumol Clin; 2002 Nov; 58(5 Pt 2):3S31-2. PubMed ID: 12538932
    [No Abstract]   [Full Text] [Related]  

  • 18. Adjuvant chemotherapy in new stage II pN0 non-small cell lung cancer: a new issue for a case-by-case decision making process.
    De Pas T; de Braud F; Veronesi G
    J Thorac Oncol; 2010 May; 5(5):754. PubMed ID: 20421773
    [No Abstract]   [Full Text] [Related]  

  • 19. [Chemotherapy for lung cancer].
    Kurata T; Fukuoka M
    Nihon Rinsho; 2002 May; 60 Suppl 5():309-16. PubMed ID: 12101679
    [No Abstract]   [Full Text] [Related]  

  • 20. [Role of chemotherapy in the treatment of advanced stage non-small-cell bronchial cancer].
    Sculier JP
    Rev Mal Respir; 1993; 10(4):287-9. PubMed ID: 8235020
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.